http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2729659-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d28147fc930e0800b6b980a94d9da48 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-40 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-472 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2f58477ac70d09d677cd346464eae1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1246e04d965c54b30951c83c321ffd13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0816edf165f351ff947d7eed46de86e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ed3b8bebb938b2c1da435f3a1c53a5 |
| publicationDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2729659-C1 |
| titleOfInvention | Dosage form for releasing drotaverine in oral cavity |
| abstract | FIELD: medicine; pharmaceuticals. n SUBSTANCE: group of inventions relates to the pharmaceutical industry, specifically to a dosage form releasing an active substance in the individual's oral cavity, based on drotaverine. Dosage form releasing an active substance in the oral cavity of the subject, containing drotaverine as an active substance or its pharmaceutically acceptable salt in a therapeutically effective amount and a pharmaceutically acceptable carrier providing a form releasing an active substance in the oral cavity, characterized by that it contains drotaverine or its pharmaceutically acceptable salt in form of a complex with a taste masking agent in a weight ratio of 1:1 to 1:10, wherein the taste masking agent is cyclodextrin. Method for administering drotaverine into a subject, comprising placing the dosage form in an individual's oral cavity. n EFFECT: above described dose of drotaverine releases active component in oral cavity and has good taste characteristics. n 5 cl, 5 tbl, 5 ex |
| priorityDate | 2019-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 89.